The FDA published more than 200 complete response letters, the first step in what it describes as part of its effort to modernize the agency and improve transparency. But there are some caveats to the release of the FDA correspondence. The post Pledging ‘Radical Transparency,’ FDA Reveals Drug Rejection Letters — With Limits appeared first…
The cruel irony is that incredibly effective treatments already exist. Many people, however, cannot access them due to barriers to care The post A Massive Wave of Eye Disease is Coming, and Healthcare is Unprepared appeared first on MedCity News.
In this month’s episode, Senior Reporter Katie Adams discussed some of the executive moves, exits and layoffs that recently occurred in the healthcare world. She also interviewed Amy Abernethy, who recently co-founded Highlander Health with fellow healthcare veteran Brad Hirsch. The post MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Amy Abernethy, Co-Founder…
We need to evaluate agentic AI through the specific lens of the healthcare industry and its workflows, evaluating the needs of providers, healthcare organizations as well as patients, recognizing that healthcare is not monolithic and will have workflows that are more appropriate than others for implementing AI. The post Why Agentic AI Is Not Quite…
Suzy Lohman felt compelled to act when she learned that foster children treated at Cincinnati Children’s Hospital Medical Center often lacked proper bags for their belongings. Inspired by a hospital newsletter request for suitcases, duffel bags, and backpacks, Suzy launched a drive among EVS employees to collect these essential items. Many foster children, she knew, relied…
In this month’s episode, Senior Reporter Katie Adams discussed some of the executive moves, exits and layoffs that occurred recently in the healthcare sector. She also interviewed Claire Zangerle, who was appointed as chief nurse executive of the American Hospital Association, as well as CEO of its American Organization for Nursing Leadership. The post MedCity…
Rocket Pharmaceuticals adjusted the clinical trial design to include use of approved drug to avert an excessive immune response to its Danon disease gene therapy. The patient who died was one of two who received this drug under the revised protocol. The post Death in Rocket Pharma Gene Therapy Study Puts Spotlight on Trial Change…
California’s controversial experiment to order mental illness and drug treatment for some of its sickest residents is rolling out statewide, but the latest data shows the new initiative is falling far short of early objectives. The Community Assistance, Recovery and Empowerment Act — known as Care — recently expanded from 11 pilot counties to all…
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
If the guidelines for data sharing are not adhered to by providers, then all the work that has gone into revising this regulation will have been for nothing. But the road to compliance doesn’t have to be overwhelming. Here are three essential steps for healthcare leaders in navigating the soon-to-be Part 2 landscape. The post…